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Although fever is  a  well-known manifestation  of some  allergic  or  immune 
states,  its pathogenesis in these situations remains  obscure.  Previous  studies 
have demonstrated that animals immunized with protein  antigens will readily 
respond  with  fever  upon  challenge  with  specific  antigen  (1,  2).  In rabbits 
immunized and then challenged with human serum albumin  (HSA), the febrile 
response has been shown to be proportional to both the antigen dose and titers 
of circulating antibody (2).  Furthermore,  the capacity to develop fever upon 
challenge can be passively transferred  to normal rabbits only by using serum 
which contains measurable  antibody  (2,  3).  These findings indicate  that hu- 
moral antibodies participate in an essential manner in the etiology of this exper- 
imental fever.  The present  investigations  were undertaken  to determine how 
antigen  and  antibody interact  within  the host to produce fever.  The results 
suggest that the formation of circulating antigen-antibody complexes probably 
play an important initial role in the pathogenesis of the febrile response. 
Materials and Methods 
New Zealand albino rabbits from the National  Institutes of Health colony weighing from 
1750 to 2800 g were used throughout the study. Details of their housing, the recording of tem- 
peratures,  plotting of fever curves, immunization with HSA,  1 injections and bleedings, and 
precautions  to exclude contaminating  pyrogens were as reported  previously  (2). All serum 
pools were checked for sterility by culture on blood agar plates and in thioglycollate broth, and 
contaminated  material was discarded. Sera were stored at either --20°C or -- 70°C until used. 
Antibody Determinations.--Antibody titers  were measured in serial two-fold dilutions  of 
serum using the bentonite flocculation technique as previously described (2). Precipitin equiva- 
lence zones were determined  by the addition of increasing amounts of I~I-HSA2 in 0.1  ml 
volumes to 0.5 or 1.0 ml quantities of whole immune serum. The l~I-HSA-serum mixtures were 
then incubated  at 37°C for 1 hr and 4°C for 2--4 days. At the conclusion of the incubation 
period, the antigen-antibody precipitates were removed by centrifugation (2000  g for 30 rain at 
1 Courtland Laboratories, Los Angeles, Calif. 
2 Kindly prepared by W. H. Briner, Chief, Radiopharmaceutieal  Service, N.I.H., Bethesda, 
Md. 
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4°C) and washed twice with phosphate-buffered pH 7.4, 0.15 g  saline (PBS). The activity of 
the I~I-HSA in the precipitates was determined by counting in a NaI crystal well scintillation 
counter? The total activity of the I~I-HSA added at each concentration was determined by 
counting the protein precipitates formed after addition of 10% trichloroacetic acid  (TCA). 
Thus, the per cent antigen precipitated by the antiserum at each concentration could be cal- 
culated by comparison with the total counts. The end point of the equivalence zone was indi- 
cated when the amount of antigen added was no longer totally precipitated by antibody. 
Standard precipitin-ring tests were also done on the supernatants remaining after removal by 
centrifugation of antigen-antibody precipitates to confirm the absence of free precipitating 
antibody at the equivalence point (4). 
,Passive Transft~  Stud/es.--At intervals (5 min and 2 hr) after intravenous challenge with 25 
mg of HSA, immunized and normal rabbits were exsanguinated under sterile conditions by 
cardiac puncture and the blood allowed to clot at room temperature for 1-1.5 hr before storing 
overnight at 4°C. The next day serum was separated by centrifugation and cultured. Sera from 
immune donors obtained 2 hr after HSA challenge (2-hr serum) were divided into two groups 
and pooled: (a) those that were from febrile donors (temperature >  0.3°C above base line) at 
the time of bleeding, and  (b) those that were from afebrile donors.  Sera from normal donor 
rabbits (all afebrile) were simUarly pooled. The sera obtained 5 min after HSA challenge (5- rain 
serum) from immune and normal donors were also pooled, cultured, and stored at 4°C  until 
used. In several experiments in which blood was obtained 5 rain after HSA challenge, heparin 
(10 units/ml) was added, the ceils removed by centrifugation, and the plasma saved for dem- 
onstration of circulating pyrogens. 
Assay for pyrogens in donor sera or plasma was performed by intravenous transfer into 
trained, normal, or endotoxin-tolerant recipient rabbits. Preliminary experiments indicated 
that greater than 20 ml volumes (approximately 10 ml/kg) were required to consistently dem- 
onstrate the presence of circulating pyrogens, so approximately 20 ml/kg volumes were used 
unless otherwise noted. All sera were incubated 15-30 rain at 37°C prior to infusion. 
Clearanc~ of t~I-HSA in Immune and Normal Rabbits.--25 mg of I~5I-HSA were adminis- 
tered to normM and immunized rabbits and serial blood samples were obtained. Serum was 
separated by centrifugation, and the total I~I-HSA activity was measured  in 50 or  100 ~tl 
aliquots by counting precipitates formed after the addition of 10% TCA.  Values for serum 
volume were calculated in 10 normal rabbits by extrapolating the linear portion of the clear- 
ance curves to zero time and determining the volume of distribution of the 12SI-HSA initial 
activity. Expressed as a function of body weight, the mean value for serum volume was found 
to be 45 ml/kg. Using this tatter figure, the body weight of the immunized rabbits and the 
radioactivity of the 25 mg dose of I~I-HSA, initial or 100% values were determined for the 
immune serum aliquots. Subsequent values were then expressed as a  per cent of this initial 
figure and clearance curves constructed. 
The amount of HSA bound to antibody was determined using a  modification of the Farr 
technique (5, 6). After dilution of either a 50 or 100/~1 aliquot of serum in 1 ml of PBS plus 1 
ml of borate buffer (pH 8.4), 2 ml of saturated ammonium sulfate (AS) were added to precipi- 
tate the globulins (final concentration of AS, 1/2 saturated). After incubation  at 4°C for 30 min, 
the precipitated globulins were centrifuged in the cold at 2500 g for 30 rain, washed once in 
half-saturated AS, and the precipitates counted.  Using the per cent of the initial activity re- 
maining at each time interval, a  clearance curve for soluble antigen-antibody complexes was 
then constructed. The amount of I~I-HSA bound to antibody was also calculated at each time 
interval as a per cent of the total (TCA-precipitable) activity. 
Formation of Soluble Antlgen-Antibody Comp/exes.--Immune precipitates  were formed at 
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equivalence by the addition of an appropriate amount of HSA to whole immune serum. The 
mixture was kept at room temperature or incubated at 37°C for 1 hr, then overnight at 4°C. 
Soluble complexes in antigen excess were formed the next morning  by the addition of HSA 
directly to the immune serum containing the precipitates or to precipitates removed by cen- 
trifugation (2000 g), washed twice in PBS, and resuspended in normal serum. In some experi- 
ments, soluble complexes were formed without overnight incubation by the addition of excess 
antigen to whole immune serum. After shaking the mixtures at room temperature for 30 to 45 
min, any remaining precipitates were removed by centrifugation (2000 g for 30 min at 4°C). 
The supernatants containing the soluble antigen-antibody complexes were then incubated at 
37°C and injected intravenously into rabbits to test for pyrogeuic activity. Using the tech- 
uique described for determination of soluble complexes of antibody-bound 126I-HSA, it was 
found that when 10 times the amount of antigen required to precipitate antibody at equiva- 
lence was added to precipitates, approximately 50% of the activity in the superImtant was 
bound to antibody as soluble complexes with the remainder consisting  of free antigen. To 
insure that serum and antigen solutions were pyrogen free, separate equivalent amounts of 
each were administered to control rabbits. 
Tolerance to Endotoxin.--Normal rabbits were made tolerant to the pyrogenic activity of 
Escheriehia coli endotoxin by seven daily  intravenous injections of 3 #g.4 
Tolerance to Comp/exes.--Febrile unresponsiveness  to soluble antigen-antibody complexes 
was produced by daily (five to six) intravenous infusions of 20 ml amounts of soluble complexes 
prepared in antigen excess at 10 times equivalence ("10 X complexes"). 
RESULTS 
Circulating Serum Pyrogens.-- 
2-hr serum pyrogen: A  pyrogen was demonstrated in the circulation of febrile 
immunized donors 2 hr after challenge with HSA by the production of fever in 
normal or endotoxin-tolerant recipient rabbits receiving passively transferred 
serum (Table I). This pyrogen was not found in the serum of immunized donors 
of comparable antibody titer nor  in normal donors, both  of whom  had been 
challenged with  HSA but  remained  afebrile (Fig.  1).  In  all cases,  the  fever 
curves were monophasic; after a  latent period of 10 to 30 rain, peak tempera- 
tures were  reached by 60-80  rain. 
5-rain serum pyrogen: The pyrogen demonstrable in the circulation of febrile 
immunized rabbits 2 hr after challenge with HSA appeared to have the char- 
acteristics of endogenous serum pyrogen (EP). This material is known to appear 
only during fever (7) ; therefore, to investigate this feature of the 2-hr pyrogen, 
serum was obtained from immunized donor rabbits 5 rnin after challenge with 
25 mg of HSA and infused into normal recipients. Despite the absence of fever 
in the donor rabbits, a transferable pyrogen was also present at this time (Table 
I, Fig. 2). Like the 2-hr serum pyrogen, recipient fever curves were monophasic 
but had a latent period varying from 30 to 40 rain and reached a peak by 80-150 
min. 
Clearance of lISA in Immunized and Normal Rabbits.--Further experiments 
were undertaken to elucidate the nature of this early appearing pyrogen and to 
4 Difco Laboratories, Detroit, Mich. 312  PATHOGENETIC MECHANISMS  IN IMA~ITN~ FEVER 
TABLE  I 
Pyrogenic  Properties  of  Passively  Transferred  Serum from  HSA-Immunized  Rabbits  after 
Challenge  with  25  mg  HSA 
Donor 
Immune 
Normal 
Immune][ 
(afebrlle) 
Immune 
Immune 
Immune 
Normal 
Recipient 
Norl~al 
gc 
Normal 
Endotoxin- 
tolerant 
Normal 
No. of  Time  serum  aT*  recipients  obtained 
°C 
12  2  hr  0.81  -4-  0.10§ 
3  2  "  <0.2 
3  2  "  <0.2 
2  " 
5 min 
5  u 
0.67  4-  0.13¶ 
0.59  4-  0.11¶ 
0.95  4-  0.08 
<0.2 
5-hr FI$ 
10.5  q-  1.3 
0 
0 
8.5  4-  2.1¶ 
5.4  4-  1.2¶ 
15.3  4-  4.5 
0 
*AT is the maximum change in temperature above the base line in °C. 
FI is the fever index (see text) in cm  2 for 5 hr after challenge. 
§ Mean 4- standard error. 
[[ The donor rabbits all had antibody titers (bentonite flocculation) of 1:32 but did not 
develop fever upon challenge with HSA. 
¶  Differences are not significant (t test). 
I.O 
|  /Febrile Immune Donor 
J  /Serum  (12) 
O, 8 V  .~1~  Afebrile  Immune Donor. 
0.6 
0.4 
<1 
I  I  I  I  I  I 
0  I  2  3  4  5 
TIME  (HOURS) 
FIC. I.  Mean febrile responses of normal recipients (number of rabbits in parentheses) 
following the infusion at 0 time of 40 ml of sera obtained from normal donor rabbits (a--A), 
afebrile immune donor rabbits (m-l),  and febrile immune donor rabbits  (e--e) 2 hr after 
intravenous challenge with 25 mg of HSA. RICHARD  K. ROOT  AND  SHELDON  x~. WOLf'S"  313 
attempt to separate it from the pyrogen circulating during fever. The clearance 
of intravenously administered HSA was examined in normal and immune rab- 
bits.  25 mg doses of 12SI-HSA were given,  and  serum obtained at appropriate 
intervals thereafter was analyzed for the presence of total and antibody-bound 
HSA by the TCA and ammonium sulfate precipitation techniques. 
Fig. 3  illustrates the mean febrile response of four immune rabbits of corn- 
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0.8  /,,  Immune  Serum  (8) 
0.6 
m  0.4 
o 
<3 
0  I  2  3  4  5 
TIME  (HOURS) 
FIG. 2.  Mean febrile responses of normal recipient rabbits (number  of rabbits in paren- 
theses) following the infusion at 0 time of 40 ml of sera obtained from normal donor rabbits 
(A--A) and immune donor rabbits (O--e) 5 min after the administration of 25 mg of HSA. 
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FIG. 3.  Mean febrile responses of normal  (O--O)  and HSA immunized  (e--O) rabbits 
(number  of rabbits in parentheses)  following the intravenous administration of 25 mg I¢sI- 
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parable  antibody  titers  challenged  with  n~I-HSA.  In  Fig.  4  the  mean  4-hr 
clearance curves of total  (immune)  and antibody-bound  (immune complexes) 
serum ~25I-HSA  activity  in the same immunized rabbits  are compared to the 
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FIG. 4.  Serum clearance of I~I-HSA administered at 0 time to normal and HSA-immunized 
rabbits  (number of rabbits in parentheses).  Data is illustrated  as the mean  4-  1 sE for total 
(TCA-precipitable)  I~I-I-ISA activity in normal  (.--.)  and immunized  rabbits  (--)  as well as 
clearance of soluble HSA-anti-HSA complexes  (ammonium sulfate precipitable activity)  in the 
same immunized rabbits  (- -  -). The percentages  given in parentheses refer to the mean anti- 
body bound radioactivity at each time interval. 
mean  clearance  curve  for  total  t~sI-HSA  activity  in  10  normal rabbits.  Not 
shown are the values for ammonium sulfate precipitable  mI-HSA  activity  in 
the normal rabbit sera which varied from 2 to 5 per cent of the total activity at 
all time intervals examined. The clearance of the antigen in the immune rabbits 
occurred in  a  biphasic manner with an early rapid  phase followed by a  more RICHARD  K.  ROOT  AND  SHELDON  M.  WOLFF  315 
prolonged slower phase. As indicated by the values in parentheses in Fig. 4, 
approximately 50% of the total I~SI-HSA activity in the immune serum at each 
time interval during the first 2 hr was bound to the globulin fraction and rep- 
resented  circulating soluble antigen-antibody  complexes.  When  the  amounts 
of circulating complexes in the immune sera,  expressed  as per cent of the total 
initial activity, were compared at 5 rain to those at 2 hr,  approximately 50 % 
of the complexes had been cleared from the circulation between the two time 
intervals (range,  46.3-51.5 %; mean, 50.1%) (Table II, Fig. 4). These findings 
suggested that  the early pyrogenic factor might well be circulating  antigen- 
antibody complexes. 
TABLE  II 
Clearance  of Soluble 125I-HSA-Anti-tISA  Complexes  in Immune Rabbits after Administration 
of a2sI-HSA * 
Immune rabbit 
No. 
Bentonite 
flocculation titer 
1:512 
1:128 
1:128 
1:128 
Antibody-bound HSA remaining 
5 mill  I  2 hr 
Clearance of soluble 
complexes from 
5 rain to 2 hr 
% initial acti~ity$ 
49.5  24.0 
37.6  16.5 
37.2  19.9 
29.9  17.2 
38.5  19.4 
% 5-mln activity§ 
51.5 
56.0 
46.5 
46.3 
Mean .........................  50.1 
*Dose, 125I-HSA  =  25 mg given intravenously. 
:~ Amount  of I~SI-HSA bound  to  serum  globulin  as  determined by  ammonium  sulfate 
precipitation (see text) and expressed as per cent of total administered activity. 
§ Calculated by expressing the difference between ammonium sulfate precipitable activity 
found at 5 rain and 2 hr as per cent of the S-rain activity. 
Pyrogenic Activity  of Soluble Antigen-Antibody Complexes.--The  pyrogenic 
properties of soluble antigen-antibody complexes  prepared  in vitro were next 
examined.  In the initial experiments,  soluble complexes were formed by adding 
excess  antigen  to immune precipitates  in  the original  immune serum.  Mter 
removal of the remaining  precipitates by centrifugation, the supematants con- 
taining the soluble complexes were infused into normal rabbits in approximately 
10 ml/kg (20 ml) amounts. This produced characteristic febrile responses which, 
with rare exceptions,  were preceded by a latent period of 30 to  50 mill;  were 
monophasic in type, reaching  a peak temperature by 90 to  100 rain after chal- 
lenge; and lasted from 4 to 6 hr (Table III,  Fig.  5). These fevers were similar 
to those exhibited by immlmized  animals  challenged  with HSA (2) or normal 
rabbits administered  the 5-rain  serum.  It was found that  soluble complexes 
formed by the addition of 10 times the amount of antigen required to precipitate 
antibody at equivalence ("10 X  complexes") elicited  the most regular febrile 316  PATHOGENETIC  MECHANISMS  IN  IMMUNE  FEVER 
responses. As indicated in Table III, complexes produced by adding 21 or 3  X 
equivalence amounts of HSA caused generally smaller and more variable fevers. 
When animals were made tolerant to the pyrogenic action of E. coli endotoxin, 
TABLE HI 
Pyrogenic Properties o.f Soluble HSA-Anti-HSA  Complexes Prepared In  Vitro 
Complexes: 
degree of 
antigen excess* 
10 X equiv- 
alence 
10 X equiv- 
alence 
21 X equiv- 
alence 
3 X equiv- 
alence 
5-18 X 
equiv- 
alence 
5-18 X 
equiv- 
alence 
Sone 
~one 
~one 
HSA 
bound at 
equivalence/ 
ml antiserum 
~g 
0.325 
0.160 
O. 150 
0.325 
0.150-0.200 
0.150-0.200 
m 
r 
Serums 
Immune 
Normal 
Normal 
Normal 
Immune 
Immune 
Immune** 
super- 
natant 
Immune 
Normal;~ 
HSA 
Recipient 
Normal 
Normal 
Normal 
Normal 
Normal 
Endo- 
toxin 
tolerant 
Normal 
Normal 
Normal 
No. 
11 
10 
9 
5 
20 
~c 
1.0o ::i: 0.09¶ 
0.72 4- 0.12 
0.58 q- 0.08 
0.47 ±  0.15 
0,63.4.- 0.10 
0..50 -4- 0.12 
<0.2 
<0.2 
<0.2 
$-hr FII[ 
onJ 
16.7 -4- 2.T 
11.1 q- 0.9 
9.2 q-  1.8 
7.2 -4- 3.6 
8.3 ±  1.9 
9.1-4- 3.3 
0 
0 
* Amount of HSA X amount bound at equivalence used to solubilize complexes. 
;~ Complexes solubilized in either immune or normal serum and administered in a dose of 
20 ml/rabbit. 
§  AT is the maximum change in temperature above the base line in °C. 
[[ FI is the fever index (see text) in cm  ~  for 5 hr after challenge. 
¶ Mean -I- standard error. 
** Immune serum remaining after antigen-antibody  precipitates removed at equivalence. 
~:~ Normal rabbit serum containing the same amount of HSA used to solubilize  complexes. 
their febrile responses did not differ significantly from normal recipients given 
equivalent doses of soluble complexes in immune serum (Table III). Further 
confirmation that soluble complexes were the pyrogenic factor in the immune 
serum containing excess antigen was obtained by removing antigen-antibody 
precipitates  from  immune serum  at  equivalence and  resolubilizing them  in RICHARD K. ROOT AND  SHELDON  M. WOLI~'~'  317 
normal serum with excess HSA. Such normal sera containing the soluble HSA- 
anti-HSA complexes were regularly pyrogenic when infused (20 ml doses) into 
recipient  rabbits,  whereas  the  immune serum  supematant remaining  after 
removal of the precipitates was not (Table III). 
Finally, it was  observed  that animals receiving  complexes also  exhibited 
frequent immediate reactions suggestive of acute anaphylaxis and characterized 
by agitation, struggling,  nystagmus, cyanosis and, rarely, death within 2 to 
3min. 
I.O I--  10X Soluble 
~  0.6 
0.4 
N  o 
0  I  2  3  4  5 
TIME  (HOURS) 
FzG. 5. Mean febrile responses  of normal rabbits (number of rabbits in parentheses) follow- 
ing the infusion at 0 time of 10 m]/k~;  of either immune serum containing soluble complexes 
prepared at 10  X  equivalence (e--e), normal serum containing an equal amount of HSA 
(I-l),  or immune serum alone (A--&). 
Febrile Tolerance to Antigen-Antibody  Complexes.--Having  demonstrated that 
soluble antigen-antibody complexes prepared  in vitro were pyrogenic, the next 
series of experiments was designed to produce a state of febrile unresponsiveness 
(tolerance)  to complexes. These experiments were performed  in order  to learn 
if fever caused by in vivo formed complexes in test sera could be separated from 
that due to endogenous pyrogen. As shown in Fig. 6 and summarized in Table 
IV,  normal rabbits receiving  daily infusions  of  10  X  soluble  complexes in 
immune serum showed diminished febrile responses by 24  hr after the initial 
dose. Characteristically,  on the second day the febrile responses were abolished 
almost entirely, with a  tendency to rebound somewhat  on  day" 3. This was 
followed again by minimal, if any, responses on days 4--6. In addition to reduc- 
tion in febrile responses with succeeding doses, there  was a  concomitant de- 
crease in the anaphylactic type responses. Complex-tolerant  rabbits responded 
normally to E. coli endotoxin (Table IV), indicating that endotoxin contamina- 
tion was not responsible for the tolerant state. 318  PATHOGENETIC  MECHANISMS  IN  1MMUNE FEVER 
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FIC. 6.  Mean febrile responses of normal rabbits (number in pzrentheses) given a  daily 
intravenous injection of 10 ml/kg of immune serum containing soluble antigen-antibody com- 
plexes prepared at 10 X  equivalence. The figures demonstrate the development of pyrogenic 
tolerance. 
TABLE  IV 
Responses of Complex-Tolerant Rabbits to Various Pyrogens 
Test material 
HSA-anfi-HSA 
soluble 
(10 X) complexesll 
2 hr serum 
5 min serum 
0.1 #g endotoxin 
Recipient 
NormaI (day 1) 
Complex toler- 
ant (day 4) 
Complex toler- 
ant (day 4-5) 
Normal 
Complex toler- 
ant (day 4) 
Normal 
Complex toler- 
ant (day 6) 
Normal 
AT* 
°c 
1.02 4- 0.07¶ 
0.25 4- 0.08 
0.54 4- 0.04 
0.55 4- 0.O8 
0.22 4- 0.06 
0.77 4- 0.15 
1.75 4- 0.08 
1.77 4- 0.08 
5-hr Fit 
c~s 
16.9 4- 2.1¶ 
1.9 4- 0.8 
3.4 4- 0.3 
7.7 4- 2.0 
2.4 4- 2.3 
11.9 4- 1.0 
30.3 4- 2.4 
33.5 4- 1.9 
2-hr FI§ 
Cm2 
3.4 4- 0.3 
4.6  4-  0.6 
* AT is the maximum change in temperature above the base line in °C. 
FI is the fever index (see text) in cm  s for 5 hr after challenge. 
§ The fever index (see text) in cm  2 for 2 hours after challenge. 
[[ Complexes selubilized in immune serum  in 10 X  antigen excess (0.350-0.400 mg HSA 
bound at equivalence/ml antiserum) and administered in 20 ml doses. 
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Febrile Reactivity of Complex-Tolerant RabMts to 5-rain and 2-hr serum.--Mter 
the induction of febrile tolerance to soluble complexes by three or four daily 
infusions, animals were given either 2-hr serum or 5-rain serum or plasma (in 
40  ml quantities)  obtained from HSA-chaUenged immune donor  rabbits  in 
order to separate pyrogenicity due to complexes from that due to endogenous 
pyrogen. As shown in Fig. 7 and summarized in Table IV, the 2-hr serum evoked 
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FIG. 7. Mean febrile responses of six normal and eight complex-tolerant rabbits adminis- 
tered 40 mi of serum obtained  from febrile  immunized  donors  2 hr after challenge  with 25 mg 
HSA (see text). 
similar temperature rises in both normal and complex-tolerant rabbits.] On the 
other hand, the pyrogenic activity of the 5-rain serum was significantly  reduced 
in  complex-tolerant  animals  when  compared  to  their  normal  counterparts 
(Table IV, Fig. 8). These results strongly suggested that the early-appearing 
circulating pyrogen consisted of soluble antigen-antibody complexes, and the 
later appearing factor was indeed endogenous pyrogen. The fact that the fevers 
were somewhat less prolonged in the tolerant recipients given 2-hr serum as 
demonstrated when 2-hr and 5-hr fever indexes (Frs) are compared (Table IV) 
is compatible with the persistence of some soluble complexes in the 2-hr serum. 320  PATHOGENETIC MECHANISMS  IN ~UNE  ]~EVER 
DISCUSSION 
In some patients undergoing febrile transfusion reactions, circulating platelet 
and  leukagglutinins  have been shown to play a  causal role (8).  In addition, 
fever regularly  accompanies  experimentally  induced  or  naturally  occurring 
immune hemolysis, which involves the interaction of hemolysins with foreign 
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FIO. 8.  Mean febrile responses of 9 normal and 10 complex-tolerant rabbits following infu- 
sion of 40 ml of serum or plasma obtained from immunized donors 5 rain after challenge with 
25 mg HSA (see text). 
RBC's (9). In the initial studies of Farr and his associates with rabbits given 
BSA, the importance of the presence of circulating antibody to the subsequent 
development of fever on challenge with a protein antigen was demonstrated by 
passive transfer experiments (3). These observations were exDanded  by Mott 
and  Wolff using  HSA-immunized  rabbits  when  a  quantitative  relationship 
between febrile response,  antibody titer, and antigen dose was established (2). 
Thus, it seemed apparent that the interaction of antigen and circulating  anti- 
body in the host resulted in fever in these clinical and experimental conditions. 
The actual mechanism whereby fever developed in these situations remained 
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A considerable body of evidence exists that many fevers are mediated by an 
EP released into  the circulation from host leukocytes after interaction  with 
exogenous  agents such as endotoxin (10).  Accordingly,  the initial  aim of the 
current studies was to see if the interaction of circulating antibody with intra- 
venously administered antigen resulted in the appearance of EP. A transferable 
pyrogen with biological  characteristics  consistent with EP  (i.e.,  monophasic 
fever,  short  latent  period,  and  fever production  in  normal  and  endotoxin- 
tolerant rabbits) was demonstrated in sera obtained from febrile immune donors 
However, when sera were obtained from immune donors challenged  with HSA 
prior to the development of fever, this also contained a pyrogen as demonstrated 
by infusion into normal recipients.  Since EP is known to appear only at the time 
of fever (7), this finding suggested that some other early appearing circulating 
pyrogenic factor was also present in immunized donors challenged with antigen. 
By using HSA-labeled with l~sI and a modification of the Farr technique to 
detect antibody-bound HSA, it was determined that a considerable portion of 
the administered antigen appeared in the circulation in combination with anti- 
body as soluble antigen-antibody complexes. Evidence was then obtained that 
the  early  appearing  transferable  pyrogen  represented  circulating  soluble 
antigen-antibody complexes.  First, such complexes prepared in antigen excess 
in vitro were found to be regularly pyrogenic when administered to either nor- 
mal or endotoxin-tolerant recipients.  Second,  by administering  daily doses of 
complexes to rabbits, febrile responses to subsequent infusions could be abol- 
ished,  and when such "complex-tolerant" rabbits were given sera obtained 5 
rain after challenge  of immune rabbits with antigen,  their responses were sig- 
nificantly less than normal controls. On the other hand,  the infusion  of sera 
obtained from febrile immune donors 2 hr after challenge  with antigen caused 
equal temperature rises in normal and complex-tolerant recipients,  indicating 
that this pyrogen, most likely EP, differed from the early appearing factor. The 
fact that the temperature responses in the normal rabbits were somewhat more 
prolonged than  in the complex-tolerant rabbits given 2-hr  serum can be ex- 
plained by the presence of both soluble complexes  and EP in the 2-hr  serum 
acting as pyrogenic factors. 
In relation to these findings, it is of interest that antigen-antibody complexes 
are known to be capable of initiating  a  variety of biological  phenomena  in 
various species,  including  anaphylaxis (11-14), serum sickness  (15), nephritis 
(16, 17), and Arthus reactions (18). Their role in this latter reaction is particu- 
larly significant  in light  of the present  studies,  since  the Arthus  reaction is 
known  to  require  the  intimate  participation  of host  leukocytes for  its full 
elaboration (19). In vitro studies have shown that antigen-antibody complexes 
are  chemotactic to  (20)  and  can be phagocytized by leukocytes (21),  with 
resultant  degranulation  and  release  of certain  permeability factors  (22).  It 
seems reasonable, therefore, to speculate that complexes  formed in vivo may 
activate host leukocytes to release leukocytic pyrogen, thereby inducing fever. 322  PATHOGENET~MECHANISMS  IN  IMMUNE  FEVER 
One the basis of our findings, therefore, it may be hypothesized that the fever 
produced by the interaction of circulating antigens with antibodies follows a 
biphasic reaction. The first phase consists of the formation of antigen-antibody 
complexes, both soluble and  insoluble,  and the second phase consists of the 
elaboration of an endogenous pyrogen, presumably from host leukocytes which 
have been activated after ingestion of antigen-antibody complexes. This hy- 
pothesis might be summarized as follows: 
Ag +  Ab --* Ag -- Ab complexes +  WBC --* EP 
In this regard,  the failure of HSA alone to release pyrogen from leukocytes 
obtained from sensitized donors (23) 6 might support the concept of the require- 
ment for complex formation between antigen and serum antibodies in the first 
phase of the pyrogenic reaction. We are currently examining in detail the ability 
of antigen-antibody complexes to release pyrogen from normal and sensitized 
leukocytes, the results of which will form the basis for a later report. 
SUMMARY 
When  rabbits sensitized  to human  serum albumin (HSA)  are challenged 
intravenously with specific  antigen,  fever  develops and two transferable  pyro- 
gcns can  be demonstrated in  the  circulation.  The first  appears prior  to  the  devel- 
opment of fever  and has properties  consistent  with soluble  antigen-antibody 
complexes. These have been shown to  be pyrogenic when prepared in  vitro  and 
to produce a state of febrile  tolerance when repeatedly administered. The 
second pyrogen, demonstrable during fever in donor rabbits, appears to be 
similar to endogenous pyrogen described in other experimental fevers.  It is 
postulated that the formation of antigen-antibody complexes constitutes  an 
important initial  phase of the febrile  reaction in this  type of immune fever. 
Thc  authors  gratefully  acknowledge  thc  expert  technical  assistance  of  Mr. Stanley  B. Ward 
and  Mr.  Joseph  B.  Edelin. 
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